Alivus Life Sciences Limited (BOM: 543322)
India
· Delayed Price · Currency is INR 1,148.45
+45.25 (4.10%)
At close: Jan 21, 2025
Alivus Life Sciences Revenue
Alivus Life Sciences had revenue of 5.07B INR in the quarter ending September 30, 2024, a decrease of -14.86%. This brings the company's revenue in the last twelve months to 22.05B, down -5.61% year-over-year. In the fiscal year ending March 31, 2024, Alivus Life Sciences had annual revenue of 22.83B with 5.64% growth.
Revenue (ttm)
22.05B
Revenue Growth
-5.61%
P/S Ratio
n/a
Revenue / Employee
10.95M
Employees
2,014
Market Cap
140.90B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,398.38B |
| Tata Consultancy Services | 2,520.82B |
| HDFC Bank | 2,761.06B |
| Bharti Airtel | 1,554.78B |
| ICICI Bank | 1,638.51B |
| Infosys | 1,635.60B |
| State Bank of India | 3,360.28B |
| Hindustan Unilever | 624.10B |